SCHEMBL4574540

SCHEMBL4574540

CCN(CCCCO)C(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA14 Q9ULX7 2/20 0.53
TDP1 Q9NUW8 1/20 0.42
MLYCD O95822 1/20 0.38
SSTR4 P31391 1/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA9 Q16790 1/20 0.35
CYP4F2 P78329 4/20 0.35
CYP4A11 Q02928 4/20 0.35
HDAC3 O15379 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
NAMPT P43490 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CA7 P43166 1/20 0.33
LMNA P02545 1/20 0.32
CTSK P43235 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19772708 0.98 CA14 (0.51) CA14TDP1MLYCDSSTR4HDAC1
SCHEMBL6130651 0.95 CA14 (0.52) CA14TDP1MLYCDSSTR4HDAC1
SCHEMBL3551705 0.95 CA14 (0.50) CA14TDP1MLYCDSSTR4HDAC1
SCHEMBL15085740 0.91 CA14 (0.53) CA14TDP1SSTR4HDAC1HDAC2
SCHEMBL25797677 0.89 CA14 (0.59) CA14TDP1MLYCDSSTR4HDAC1
SCHEMBL10420506 0.89 CA14 (0.59) CA14TDP1MLYCDSSTR4HDAC1
SCHEMBL8627528 0.89 CA14 (0.59) CA14TDP1MLYCDSSTR4HDAC1
SCHEMBL19214063 0.88 CA14 (0.55) CA14TDP1SSTR4HDAC1HDAC2
SCHEMBL8628224 0.87 CA14 (0.54) CA14TDP1SSTR4HDAC1HDAC2
SCHEMBL8850983 0.87 CA14 (0.54) CA14TDP1SSTR4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008047883-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-04-24 WO disclosed